Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 31

1.

Reconstitution of T-Cell Subsets Following Thymoglobulin-Induced Depletion in High Immunologic Risk and Donation After Cardiac Death Renal Transplant Recipients.

Akbari M, Saha MN, Telfer S, Ullah S, Mok A, McAlister V, Juriasingani S, Luke PP, Sener A.

Transplant Proc. 2019 Jul - Aug;51(6):1744-1753. doi: 10.1016/j.transproceed.2019.03.024.

PMID:
31399162
2.

Endogenous H2S production deficiencies lead to impaired renal erythropoietin production.

Leigh J, Juriasingani S, Akbari M, Shao P, Saha MN, Lobb I, Bachtler M, Fernandez B, Qian Z, van Goor H, Pasch A, Feelisch M, Wang R, Sener A.

Can Urol Assoc J. 2018 Nov 20:E210-E219. doi: 10.5489/cuaj.5658. [Epub ahead of print]

3.

A novel approach to off-clamp partial nephrectomy demonstrates significant improvements in renal injury in an experimental porcine model.

Olvera-Posada D, Lin S, Aboalsamh G, Haig A, Lobb I, Grewal J, Saha MN, Sener A.

Can Urol Assoc J. 2017 Oct;11(10):E390-E395. doi: 10.5489/cuaj.4305.

4.

A Hibernation-Like State for Transplantable Organs: Is Hydrogen Sulfide Therapy the Future of Organ Preservation?

Dugbartey GJ, Bouma HR, Saha MN, Lobb I, Henning RH, Sener A.

Antioxid Redox Signal. 2018 Jun 1;28(16):1503-1515. doi: 10.1089/ars.2017.7127. Epub 2017 Aug 29.

PMID:
28747071
5.

Hydrogen Sulfide Protects Renal Grafts Against Prolonged Cold Ischemia-Reperfusion Injury via Specific Mitochondrial Actions.

Lobb I, Jiang J, Lian D, Liu W, Haig A, Saha MN, Torregrossa R, Wood ME, Whiteman M, Sener A.

Am J Transplant. 2017 Feb;17(2):341-352. doi: 10.1111/ajt.14080. Epub 2016 Nov 29.

6.

Hydrogen Sulfide Induced Erythropoietin Synthesis is Regulated by HIF Proteins.

Leigh J, Saha MN, Mok A, Champsi O, Wang R, Lobb I, Sener A.

J Urol. 2016 Jul;196(1):251-60. doi: 10.1016/j.juro.2016.01.113. Epub 2016 Feb 12.

PMID:
26880412
7.

MiRNA-29a as a tumor suppressor mediates PRIMA-1Met-induced anti-myeloma activity by targeting c-Myc.

Saha MN, Abdi J, Yang Y, Chang H.

Oncotarget. 2016 Feb 9;7(6):7149-60. doi: 10.18632/oncotarget.6880.

8.

miR-137 and miR-197 Induce Apoptosis and Suppress Tumorigenicity by Targeting MCL-1 in Multiple Myeloma.

Yang Y, Li F, Saha MN, Abdi J, Qiu L, Chang H.

Clin Cancer Res. 2015 May 15;21(10):2399-411. doi: 10.1158/1078-0432.CCR-14-1437. Epub 2015 Feb 27.

9.

Targeting phospho-MARCKS overcomes drug-resistance and induces antitumor activity in preclinical models of multiple myeloma.

Yang Y, Chen Y, Saha MN, Chen J, Evans K, Qiu L, Reece D, Chen GA, Chang H.

Leukemia. 2015 Mar;29(3):715-26. doi: 10.1038/leu.2014.255. Epub 2014 Sep 2.

PMID:
25179733
10.

Small molecule MIRA-1 induces in vitro and in vivo anti-myeloma activity and synergizes with current anti-myeloma agents.

Saha MN, Chen Y, Chen MH, Chen G, Chang H.

Br J Cancer. 2014 Apr 29;110(9):2224-31. doi: 10.1038/bjc.2014.164. Epub 2014 Apr 1.

11.

Assessment of changes in community level physiological profile and molecular diversity of bacterial communities in different stages of jute retting.

Das B, Chakrabarti K, Ghosh S, Chakraborty A, Saha MN.

Pak J Biol Sci. 2013 Dec 1;16(23):1722-9.

PMID:
24506039
12.

PRIMA-1Met/APR-246 displays high antitumor activity in multiple myeloma by induction of p73 and Noxa.

Saha MN, Jiang H, Yang Y, Reece D, Chang H.

Mol Cancer Ther. 2013 Nov;12(11):2331-41. doi: 10.1158/1535-7163.MCT-12-1166. Epub 2013 Sep 12. Erratum in: Mol Cancer Ther. 2018 May;17 (5):1143.

13.

Targeting p53 by small molecules in hematological malignancies.

Saha MN, Qiu L, Chang H.

J Hematol Oncol. 2013 Mar 27;6:23. doi: 10.1186/1756-8722-6-23. Review.

14.

Targeting p53 via JNK pathway: a novel role of RITA for apoptotic signaling in multiple myeloma.

Saha MN, Jiang H, Yang Y, Zhu X, Wang X, Schimmer AD, Qiu L, Chang H.

PLoS One. 2012;7(1):e30215. doi: 10.1371/journal.pone.0030215. Epub 2012 Jan 20.

15.
16.

RITA inhibits multiple myeloma cell growth through induction of p53-mediated caspase-dependent apoptosis and synergistically enhances nutlin-induced cytotoxic responses.

Saha MN, Jiang H, Mukai A, Chang H.

Mol Cancer Ther. 2010 Nov;9(11):3041-51. doi: 10.1158/1535-7163.MCT-10-0471. Epub 2010 Nov 9.

17.
18.

CKS1B nuclear expression is inversely correlated with p27Kip1 expression and is predictive of an adverse survival in patients with multiple myeloma.

Chang H, Jiang N, Jiang H, Saha MN, Qi C, Xu W, Reece D.

Haematologica. 2010 Sep;95(9):1542-7. doi: 10.3324/haematol.2010.022210. Epub 2010 Apr 26.

19.

MDM2 antagonist nutlin plus proteasome inhibitor velcade combination displays a synergistic anti-myeloma activity.

Saha MN, Jiang H, Jayakar J, Reece D, Branch DR, Chang H.

Cancer Biol Ther. 2010 Jun 1;9(11):936-44. Epub 2010 Jun 27.

PMID:
20418664
20.

Irradiation with carbon ion beams induces apoptosis, autophagy, and cellular senescence in a human glioma-derived cell line.

Jinno-Oue A, Shimizu N, Hamada N, Wada S, Tanaka A, Shinagawa M, Ohtsuki T, Mori T, Saha MN, Hoque AS, Islam S, Kogure K, Funayama T, Kobayashi Y, Hoshino H.

Int J Radiat Oncol Biol Phys. 2010 Jan 1;76(1):229-41. doi: 10.1016/j.ijrobp.2009.08.054.

PMID:
20005456
21.

Pharmacological activation of the p53 pathway in haematological malignancies.

Saha MN, Micallef J, Qiu L, Chang H.

J Clin Pathol. 2010 Mar;63(3):204-9. doi: 10.1136/jcp.2009.070961. Epub 2009 Dec 2. Review.

PMID:
19955555
22.

Degumming and characterization of ramie fibre using pectate lyase from immobilized Bacillus pumilus DKS1.

Basu S, Saha MN, Chattopadhyay D, Chakrabarti K.

Lett Appl Microbiol. 2009 May;48(5):593-7. doi: 10.1111/j.1472-765X.2009.02584.x. Epub 2009 Mar 16.

23.

Large-scale degumming of ramie fibre using a newly isolated Bacillus pumilus DKS1 with high pectate lyase activity.

Basu S, Saha MN, Chattopadhyay D, Chakrabarti K.

J Ind Microbiol Biotechnol. 2009 Feb;36(2):239-45. doi: 10.1007/s10295-008-0490-y. Epub 2008 Oct 28.

PMID:
18956216
24.

Thermodynamic characterization of a highly thermoactive extracellular pectate lyase from a new isolate Bacillus pumilus DKS1.

Basu S, Ghosh A, Bera A, Saha MN, Chattopadhyay D, Chakrabarti K.

Bioresour Technol. 2008 Nov;99(17):8088-94. doi: 10.1016/j.biortech.2008.03.032. Epub 2008 Apr 28.

PMID:
18445524
25.

Formation of vesicular stomatitis virus pseudotypes bearing surface proteins of hepatitis B virus.

Saha MN, Tanaka A, Jinno-Oue A, Shimizu N, Tamura K, Shinagawa M, Chiba J, Hoshino H.

J Virol. 2005 Oct;79(19):12566-74.

26.

The O139 serogroup of Vibrio cholerae comprises diverse clones of epidemic and nonepidemic strains derived from multiple V. cholerae O1 or non-O1 progenitors.

Faruque SM, Saha MN, Asadulghani, Sack DA, Sack RB, Takeda Y, Nair GB.

J Infect Dis. 2000 Oct;182(4):1161-8. Epub 2000 Aug 24.

PMID:
10979913
27.

Genomic diversity among Vibrio cholerae O139 strains isolated in Bangladesh and India between 1992 and 1998.

Faruque SM, Saha MN, Asadulghani, Bag PK, Bhadra RK, Bhattacharya SK, Sack RB, Takeda Y, Nair GB.

FEMS Microbiol Lett. 2000 Mar 15;184(2):279-84.

28.

Molecular characterization of a new ribotype of Vibrio cholerae O139 Bengal associated with an outbreak of cholera in Bangladesh.

Faruque SM, Siddique AK, Saha MN, Asadulghani, Rahman MM, Zaman K, Albert MJ, Sack DA, Sack RB.

J Clin Microbiol. 1999 May;37(5):1313-8.

29.
30.

Application of isotopes in medical problems.

SAHA MN, SEN BB.

Calcutta Med J. 1951 Apr;48(4):117-26; concl. No abstract available.

PMID:
14848687
31.

Application of isotopes in medical problems.

SAHA MN, SEN BB.

Calcutta Med J. 1951 Mar;48(3):81-91; contd. No abstract available.

PMID:
14848683

Supplemental Content

Support Center